Why the Oncology Companion Diagnostics Market Is Growing at an 11.48% CAGR
The Oncology Companion Diagnostics Market is expanding as healthcare providers increasingly use companion diagnostic tests to identify biomarkers and determine whether specific cancer patients are likely to benefit from targeted therapies. These diagnostic solutions support personalized oncology by helping guide treatment selection based on the molecular characteristics of...
0 Commentarii 0 Distribuiri 11 Views 0 previzualizare
G-0QEH8T2MGD